Table 1.
Characteristics of NSCLC patients.
Fig 1.
Immunostaining of a single lung cancer CTC isolated from patient peripheral blood.
Positive immunomagnetic selection with anti-EpCAM Ab was followed by morphological confirmation with staining for cytokeratins (cytoplasm), DAPI (nucleus), and CD45 (negative).
Table 2.
Univariate analysis between CTC count (per 7.5 mL of peripheral blood) and clinico-pathological data.
Table 3.
Multivariate analysis of the CTC positive model with adjusted odds ratios and 95% CI.
Table 4.
Association between CTC count and Ki-67 and tumor grade data.
Table 5.
Association between CTC counts and tumor marker data from NSCLC patients.
Table 6.
Prediction of NSCLC aggressiveness and TNM staging with CTCs or/and CEA.